Pharmaceuticals

Global Cord Blood Banking Services (Stem Cell) Market , Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

  • ALL22713
  • 137 Pages
  • July 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in the cord blood bank market. Cord blood market is expected to grow at 33.5% CAGR from 2012-2020. Public cord blood banks share more revenue as compared to private cord blood banks. Increase in awareness for cord blood storage by the government and private organizations is supporting the growth of UCB stem cell storage market. There are more than 200 public cord blood banks present in world funded by government and non-profit organizations.

Most of the cord blood banks are facing ethical problems regarding sample security. This factor is majorly responsible for decrease in the growth of cord blood banking. This report provides information about current trends for cord blood storage. Current pricing scenario for private cord blood banks and ethical issues faced by public cord blood banks is explained in this report.

Key players in cord blood banking industry includes; NeoStem, Inc., ViaCord, Inc., China Cord Blood Corporation, Cord Blood Registry Systems, Inc., Cord Blood America, Inc.

KEY BENEFITS

  • Market estimation made in this report are the result of analysis of primary and secondary data collected from authenticated sources
  • The report analyzes the key strategies adopted by top market players in cord blood banking industry
  • Impact analysis of top 10 factors to provide market situation to top management of UCB cord blood banks
  • Value chain analysis, Porter’s five forces, top investment pockets are analyzed and presented in detail in the report
  • Competitive landscape of key market players is analyzed to provide market intelligence of current trends
  • SWOT analysis and strategic developments are included in the report for Key players: NeoStem, Inc., ViaCord, Inc., China Cord Blood Corporation, Cord Blood Registry Systems, Inc., Cord Blood America, Inc

KEY MARKET SEGMENTS

BY STORAGE SERVICES

  • Public cord blood banks
  • Private cord blood banks

BY GEOGRAPHY

  • North America
  • Europe
  • Asia-Pacific
  • ROW

KEY AUDIENCES

  • Pharmaceutical manufacturing companies
  • Medical device manufacturing companies
  • Private and government research institutes

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION

1.2. KEY BENEFITS

1.3. KEY MARKET SEGMENTS

1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research

1.4.2. Primary research

1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE

3.2. KEY BENEFITS

3.2.1. Top impacting factors

3.2.2. Top investment pockets

3.2.3. Top winning strategies

3.3. TOP PLAYER POSITIONING

3.4. PORTERS FIVE FORCE ANALYSIS

3.5. CORD BLOOD TRANSPLANT FOR TREATMENT OF MEDICAL CONDITIONS

3.5.1. Current scenario

3.5.1.1. Lymphomas

3.5.1.2. Leukemias

3.5.1.3. Transplants for inherited metabolic conditions

3.5.1.4. Transplants for inherited immunological disorders

3.5.1.5. Blood cell proliferation disorders

3.5.2. Future use (Clinical trials)

3.5.2.1. Neurologic Diseases

3.5.2.2. Auto-Immune Diseases

3.5.2.3. Orthopedic Diseases

3.5.2.4. Cardiovascular Diseases

3.5.2.5. Becker Muscular Dystrophy

3.5.2.6. Stem cells & gene therapy for inherited disorders

3.5.2.7. Stem Cells & Gene Therapy for Inherited Disorders

3.5.2.8. Stem Cell Transplantation for New Indications

3.6. REGULATORY SCENARIOS

3.6.1. FDA Biologics License Application (FDA BLA)

3.6.2. American Association of Blood Banks (AABB)

3.6.3. Clinical Laboratory Improvement Amendments (CLIA)

3.6.4. American Association of Tissue Banks (AATB)

3.6.5. Joint Accreditation Committee - ISCT - EBMT (JACIE)

3.6.6. Human Tissue Authority (HTA) - UK

3.6.7. Foundation for the Accreditation of Cellular Therapy (FACT)

3.6.8. International Organization for Standardization (ISO)

3.6.9. NetCord

3.7. MARKET DYNAMICS

3.7.1. Drivers

3.7.1.1. Increase in R&D activities for application of cord blood

3.7.1.2. Rise in funds for public storage

3.7.1.3. Increase in prevalence of fatal chronic diseases

3.7.2. Restraints

3.7.2.1. Legal and ethical issues during collection

3.7.2.2. Difficulty of finding a match in the donor list

3.7.2.3. High processing and storage cost for cord blood

3.7.2.4. Lack of awareness

3.7.3. Opportunities

3.7.3.1. Advancement in therapeutic application

3.7.3.2. Untapped opportunities in developing regions

3.7.3.3. Initiatives to spread awareness

CHAPTER 4 CORD BLOOD BANKING SERVICES MARKET, BY STORAGE SERVICES

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. PUBLIC CORD BLOOD BANKS

4.2.1. Key market trends

4.2.2. Key growth factors and opportunities

4.2.3. Market size and forecast

4.3. PRIVATE CORD BLOOD BANKS

4.3.1. Key market trends

4.3.2. Key growth factors and opportunities

4.3.3. Market size and forecast

CHAPTER 5 CORD BLOOD BANKING SERVICES MARKET, BY GEOGRAPHY

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. NORTH AMERICA

5.2.1. Key market trends

5.2.2. Key growth factors and opportunities

5.2.3. Market size and forecast

5.2.3.1. U.S. market size and forecast

5.2.3.2. Canada market size and forecast

5.2.3.3. Mexico market size and forecast

5.3. EUROPE

5.3.1. Key market trends

5.3.2. Key growth factors and opportunities

5.3.3. Market size and forecast

5.3.3.1. France market size and forecast

5.3.3.2. Germany market size and forecast

5.3.3.3. UK market size and forecast

5.3.3.4. Rest of Europe market size and forecast

5.4. ASIA-PACIFIC

5.4.1. Key market trends

5.4.2. Key growth factors and opportunities

5.4.3. Market size and forecast

5.4.3.1. Japan market size and forecast

5.4.3.2. China market size and forecast

5.4.3.3. India market size and forecast

5.4.3.4. Singapore market size and forecast

5.4.3.5. Malaysia market size and forecast

5.4.3.6. Thailand market size and forecast

5.4.3.7. Indonesia market size and forecast

5.4.3.8. Philippines market size and forecast

5.4.3.9. Hong Kong (including Macau) market size and forecast

5.4.3.10. South Korea market size and forecast

5.4.3.11. Rest of Asia-Pacific market size and forecast

5.5. LAMEA

5.5.1. Key market trends

5.5.2. Key growth factors and opportunities

5.5.3. Market size and forecast

5.5.3.1. Latin America market size and forecast

5.5.3.2. Middle East and Africa market size and forecast

5.5.3.3. Rest of LAMEA market size and forecast

CHAPTER 6 COMPANY PROFILES

6.1. AMAG PHARMACEUTICALS, INC.

6.1.1. Company overview

6.1.2. Company snapshot

6.1.3. Operating business segments

6.1.4. Product portfolio

6.1.5. Business performance

6.1.6. Key strategic moves and developments

6.2. AMERICORD REGISTRY LLC

6.2.1. Company overview

6.2.2. Company snapshot

6.2.3. Operating business segments

6.2.4. Product portfolio

6.2.5. Key strategic moves and developments

6.3. CHINA CORD BLOOD CORPORATION

6.3.1. Company overview

6.3.2. Company snapshot

6.3.3. Operating business segments

6.3.4. Business performance

6.3.5. Key strategic moves and developments

6.4. CORD BLOOD AMERICA, INC.

6.4.1. Company overview

6.4.2. Company snapshot

6.4.3. Operating business segments

6.4.4. Business performance

6.4.5. Key strategic moves and developments

6.5. CORDLIFE GROUP LIMITED

6.5.1. Company overview

6.5.2. Company snapshot

6.5.3. Operating business segments

6.5.4. Product portfolio

6.5.5. Business performance

6.5.6. Key strategic moves and developments

6.6. CORDVIDA

6.6.1. Company overview

6.6.2. Company snapshot

6.6.3. Operating business segments

6.7. CRYO-CELL INTERNATIONAL, INC.

6.7.1. Company overview

6.7.2. Company snapshot

6.7.3. Operating business segments

6.7.4. Product portfolio

6.7.5. Business performance

6.8. CRYOHOLDCO DE LATINOAMERICA, S.A.P.I. DE C.V.

6.8.1. Company overview

6.8.2. Company snapshot

6.8.3. Operating business segments

6.9. ESPERITE N.V.

6.9.1. Company overview

6.9.2. Company snapshot

6.9.3. Operating business segments

6.9.4. Product portfolio

6.9.5. Business performance

6.10. LIFEFORCE CRYOBANK SCIENCES, INC

6.10.1. Company overview

6.10.2. Company snapshot

6.10.3. Product portfolio

6.11. NATIONAL CORD BLOOD PROGRAM

6.11.1. Company overview

6.11.2. Company snapshot

6.11.3. Operating business segments

6.12. PERKINELMER, INC.

6.12.1. Company overview

6.12.2. Company snapshot

6.12.3. Operating business segments

6.12.4. Product portfolio

6.12.5. Business performance

6.13. VIRGIN GROUP LIMITED

6.13.1. Company overview

6.13.2. Company snapshot

6.13.3. Operating business segments

6.13.4. Product portfolio

6.14. VITA 34 AG

6.14.1. Company overview

6.14.2. Company snapshot

6.14.3. Operating business segments

6.14.4. Product portfolio

6.14.5. Business performance

LIST OF TABLES

TABLE 1. PUBLIC VS. PRIVATE CORD BLOOD BANK SERVICES

TABLE 2. GLOBAL CORD BLOOD BANKING SERVICES MARKET, BY STORAGE SERVICES, 2016-2023 ($MILLION)

TABLE 3. CORD BLOOD BANKING SERVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 4. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)

TABLE 5. EUROPE CORD BLOOD BANKING SERVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)

TABLE 6. ASIA-PACIFIC CORD BLOOD BANKING SERVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)

TABLE 7. LAMEA CORD BLOOD BANKING SERVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)

TABLE 8. AMAG: COMPANY SNAPSHOT

TABLE 9. AMAG: PRODUCT CATEGORIES

TABLE 10. AMAG: PRODUCT PORTFOLIO

TABLE 11. AMERICORD: COMPANY SNAPSHOT

TABLE 12. AMERICORD: PRODUCT CATEGORIES

TABLE 13. AMERICORD: PRODUCT PORTFOLIO

TABLE 14. CCBC: COMPANY SNAPSHOT

TABLE 15. CCBC: PRODUCT CATEGORIES

TABLE 16. CBAI: COMPANY SNAPSHOT

TABLE 17. CBAI: PRODUCT CATEGORIES

TABLE 18. CORDLIFE: COMPANY SNAPSHOT

TABLE 19. CORDLIFE: OPERATING SEGMENTS

TABLE 20. CORDLIFE: PRODUCT PORTFOLIO

TABLE 21. CORDVIDA: COMPANY SNAPSHOT

TABLE 22. CORDVIDA: PRODUCT CATEGORY

TABLE 23. CRYO-CELL: COMPANY SNAPSHOT

TABLE 24. CRYO-CELL: OPERATING SEGMENTS

TABLE 25. CRYO-CELL: PRODUCT PORTFOLIO

TABLE 26. CRYOHOLDCO: COMPANY SNAPSHOT

TABLE 27. CRYOHOLDCO: PRODUCT CATEGORIES

TABLE 28. ESPERITE: COMPANY SNAPSHOT

TABLE 29. ESPERITE: OPERATING SEGMENTS

TABLE 30. ESPERITE: PRODUCT PORTFOLIO

TABLE 31. LIFEFORCE CRYOBANK: COMPANY SNAPSHOT

TABLE 32. LIFEFORCE CRYOBANK: PRODUCT PORTFOLIO

TABLE 33. NCBP: COMPANY SNAPSHOT

TABLE 34. NCBP: PRODUCT CATEGORY

TABLE 35. PERKINELMER: COMPANY SNAPSHOT

TABLE 36. PERKINELMER: OPERATING SEGMENTS

TABLE 37. PERKINELMER: PRODUCT PORTFOLIO

TABLE 38. VIRGIN: COMPANY SNAPSHOT

TABLE 39. VIRGIN: OPERATING SEGMENTS

TABLE 40. VIRGIN: PRODUCT PORTFOLIO

TABLE 41. VITA 34: COMPANY SNAPSHOT

TABLE 42. VITA 34: PRODUCT CATEGORIES

TABLE 43. VITA 34: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 1. CORD BLOOD BANKING SERVICES MARKET SEGMENTATION

FIGURE 2. TOP IMPACTING FACTORS

FIGURE 3. TOP INVESTMENT POCKETS, BY REGION

FIGURE 4. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2016)

FIGURE 5. GLOBAL CORD BLOOD BANKING SERVICES MARKET: TOP PLAYER POSITIONING

FIGURE 6. BARGAINING POWER OF BUYERS

FIGURE 7. BARGAINING POWER OF SUPPLIERS

FIGURE 8. THREAT OF SUBSTITUTION

FIGURE 9. THREAT OF NEW ENTRANT

FIGURE 10. COMPETITIVE RIVALRY

FIGURE 11. PUBLIC CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)

FIGURE 12. PRIVATE CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)

FIGURE 13. U.S. CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)

FIGURE 14. CANADA CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)

FIGURE 15. MEXICO CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)

FIGURE 16. FRANCE CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)

FIGURE 17. GERMANY CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)

FIGURE 18. UK CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)

FIGURE 19. REST OF EUROPE CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)

FIGURE 20. JAPAN CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)

FIGURE 21. CHINA CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)

FIGURE 22. INDIA CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)

FIGURE 23. SINGAPORE CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)

FIGURE 24. MALAYSIA CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)

FIGURE 25. THAILAND CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)

FIGURE 26. INDONESIA CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)

FIGURE 27. PHILIPPINES CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)

FIGURE 28. HONG KONG (INCLUDING MACAU) CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)

FIGURE 29. SOUTH KOREA CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)

FIGURE 30. REST OF ASIA-PACIFIC CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)

FIGURE 31. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)

FIGURE 32. MIDDLE EAST AND AFRICA CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)

FIGURE 33. REST OF LAMEA CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)

FIGURE 34. AMAG: NET SALES, 2014-2016 ($MILLION)

FIGURE 35. CCBC: NET SALES, 2014-2016 ($MILLION)

FIGURE 36. CBAI: NET SALES, 2014-2016 ($MILLION)

FIGURE 37. CORDLIFE: NET SALES, 2014-2016 ($MILLION)

FIGURE 38. CORDLIFE: REVENUE BY PRODUCT, 2016 (%)

FIGURE 39. CORDLIFE: REVENUE BY GEOGRAPHY, 2016 (%)

FIGURE 40. CRYO-CELL: NET SALES, 2014-2016 ($MILLION)

FIGURE 41. CRYO-CELL: REVENUE BY PRODUCT, 2016 (%)

FIGURE 42. ESPERITE: NET SALES, 2014-2016 ($MILLION)

FIGURE 43. ESPERITE: REVENUE BY PRODUCT, 2016 (%)

FIGURE 44. ESPERITE: REVENUE BY GEOGRAPHY, 2016 (%)

FIGURE 45. PERKINELMER: NET SALES, 2014-2016 ($MILLION)

FIGURE 46. PERKINELMER: REVENUE BY SEGMENT, 2016 (%)

FIGURE 47. PERKINELMER: REVENUE BY GEOGRAPHY, 2016 (%)

FIGURE 48. VITA 34: NET SALES, 2014-2016 ($MILLION)

FIGURE 49. VITA 34: REVENUE BY GEOGRAPHY, 2016 (%)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370